You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search


The drug library provides access to information on over 100 cancer drugs available for use in Canada.

Displaying Drugs List

3 Items
Other Name(s): Iressa® (AstraZeneca)
Exceptional Access Program
  • gefitinib - First-line monotherapy in locally advanced (not amenable to curative therapy) or metastatic NSCLC patients who have activating mutations of EGFR-TK, with specific criteria
Aug 2016
Other Name(s): Gemzar® (multiple brands available)
New Drug Funding Program
  • Gemcitabine - Carcinoma of Bladder or Urothelium
  • Gemcitabine - Non-Small Cell Lung Cancer (NSCLC)
  • Gemcitabine - Advanced Pancreatic Cancer
Feb 2018
Other Name(s): Zoladex® (AstraZeneca); Zoladex® LA (AstraZeneca)
ODB - General Benefit
  • goserelin
Mar 2016